Magenta Therapeutics, Inc. (MGTA): Price and Financial Metrics

Magenta Therapeutics, Inc. (MGTA)

Today's Latest Price: $10.25 USD

0.23 (-2.19%)

Updated Nov 13 8:00pm

Add MGTA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MGTA Daily Price Range
MGTA 52-Week Price Range

MGTA Stock Price Chart More Charts

MGTA Price/Volume Stats

Current price $10.25
Prev. close $10.48
Day low $10.00
Day high $10.84
50-day MA $10.36
200-day MA $12.93
52-week high $21.00
52-week low $5.31
Volume 90,700
Avg. volume 125,576
Dividend yield N/A
Market Cap 403.21M

Magenta Therapeutics, Inc. (MGTA) Company Bio

Magenta Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing medicines to bring the curative power of bone marrow transplant to patients. It is developing C100, C200, and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an ADC program to prevent acute graft and host diseases. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. The company was founded in 2015 and is based in Cambridge, Massachusetts.

MGTA Latest News Stream

Event/Time News Detail
Loading, please wait...

MGTA Latest Social Stream

Loading social stream, please wait...

View Full MGTA Social Stream

MGTA Price Returns

1-mo 2.50%
3-mo -11.56%
6-mo -38.10%
1-year 53.90%
3-year N/A
5-year N/A
YTD 79.82%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5056 seconds.